• Home
  • NEW DAY MEDICINE
  • 8 (58) 2023
  • 36 -8 (58) 2023 — Mukhamedzhanova M.Kh. — FEATURES OF DIAGNOSTICS OF HEART FAILURE AND REFRACTORY ANEMIA DEVELOPED ON THE BACKGROUND OF CHRONIC HEPATITIS C

36 -8 (58) 2023 — Mukhamedzhanova M.Kh. — FEATURES OF DIAGNOSTICS OF HEART FAILURE AND REFRACTORY ANEMIA DEVELOPED ON THE BACKGROUND OF CHRONIC HEPATITIS C

FEATURES OF DIAGNOSTICS OF HEART FAILURE AND REFRACTORY ANEMIA DEVELOPED ON THE BACKGROUND OF CHRONIC HEPATITIS C

Mukhamedzhanova M.Kh. Bukhara State Medical Institute named after Abu Ali ibn Sina

Resume

Chronic hepatitis C (HCV-infection) is one of the most pressing medical and social problems in the world, which is due to a wide, consistently high incidence and ubiquitous spread, as well as enormous economic costs for diagnostic and treatment processes.

One of the most important problems requiring study at present is cardiohepatic syndrome (CHS).

Key words: Chronic hepatitis C, cardiohepatic syndrome, refractory anemia, hepcidin, ferrokinetics.

First page

209

Last page

212

For citation: Mukhamedzhanova M.Kh. – FEATURES OF DIAGNOSTICS OF HEART FAILURE AND REFRACTORY ANEMIA DEVELOPED ON THE BACKGROUND OF CHRONIC HEPATITIS C //New Day in Medicine 2023 8 (58): 209-212 https://newdaymedicine.com/index.php/2023/08/25/l-324/

LIST OF REFERENCES:

  1. Лобзин Ю.В., Крюков Е.В., Жданов К.В. и др. Система выявления и медицинского сопровождения при HBV- и HCV-инфекциях у военнослужащих по призыву (на модели Черноморского флота) // Гепатология. 2003;1:6-10.
  2. Lavanchy D. Evolving epidemiology of hepatitis C virus. Clin. Microbiol. //Infect. 2011;17(2):107-115.
  3. Гармаева Т.Ц. Вирусные гепатиты В и С у больных заболеваниями системы крови: /автореф. дис. д-ра мед. наук. М., 2012.
  4. Fried M.W. Side effects of therapy of hepatitis C and their management // Hepatology. 2002;36(5/1):237-244.
  5. Rossotti R., Travi G., Pazzi A. et al. Rapid clearance of HCV-related splenic marginal zone lymphoma under an interferon-free, NS3/NS4A inhibitor-based treatment. A case report // J. Hepatol. 2015;62(1):234-237.
  6. Carrier P., Jaccard A., Jacques J. et al. HCV-associated B-cell non- Hodgkin lymphomas and new direct antiviral agents // Liver Int. 2015;35(10):2222-2227.
  7. Peveling-Oberhag J., Arcaini L., Bankov K. et al. The anti-lymphoma activity of antiviral therapy in HCV-associated B-cell non-Hodgkin lymphomas: a meta-analysis // J. Viral Hepat. 2016;23(7):536-544.
  8. Sulkowski M.S., Wasserman R., Brooks L. et al. Changes in haemo- globin during interferon alpha-2b plus ribavirin combination therapy for chronic hepatitis C virus infection // J. Viral Hepat. 2004;11(3):243-250.
  9. Jacobson I.M., McHutchison J.G., Dusheiko G. et al. Telaprevir for previously untreated chronic hepatitis C virus infection // N. Engl. J. Med. 2011;364(25):2405-2416.
  10. Mukhamedjanova MH Anemia in patients with interferences and interpretation of modern therapy. NDM 2021;4(36):150-152.
  11. Mukhamedzhanova M.Kh., Ahmedova N.Sh.. Determination of hepsidin in patients with chronic hepatitis associated with chf as a predictor of the severity of hepatocardial syndrome. // Art of Medicine International Medical Scientific Journal 10.5281/zenodo.7361300 2020;2(3):P.332-336.
  12. Soota K., Maliakkal B. Ribavirin induced hemolysis: a novel mechanism of action against chronic hepatitis C virus infection // World J. Gastroenterol. 2014;20(43/16):184-190.
  13. Dieterich D.T., Spivak, J.L. Hematologic disorders associated with hepatitis C virus infection and their management // Clin. Infect. Dis. 2003;37(4):533-541.
  14. Милованова С.Ю., Козловская Л.В., Лопаткина Т.Н. Анемии при острых и хронических заболеваниях печени. клиническая гепатология. 2006;2(2):16-23.
  15. Соловьева А.Е. Прогностическое значение плотности печени при декомпенсированной сердечной недостаточности: результаты проспективного обсервационного исследования на основе данных непрямой эластометрии /А.Е. Соловьева, Ж.Д. Кобалава, С.В. Виллевальде, М. Баярсайхан, И.В. Гармаш, М. Фудим // Кардиология. 2018;58(10):20-32.
  16. Болотова Е.В. и др. Актуальные вопросы диагностики, лечения и профилактики железодефицитной анемии: Учебное пособие / Е.В. Болотова, В.А. Крутова, А.В. Дудникова, Н.С. Просолупова, А.А. Сороченко – Краснодар: Кубанский гос. мед. ун-т, 2022.
  17. Воробьев П.А. Анимеческий синдром в клинической практике. М.Ньюдиамед. 2001;168.

file

download